Acurx Pharmaceuticals, Inc. (ACXP)

Price & Market Data

Price: $2.04

Daily Change: +$0.11 / 5.39%

Daily Range: $1.76 - $2.44

Market Cap: $8,466,544

Daily Volume: 250,448

Performance Metrics

1 Week: 10.83%

1 Month: -6.37%

3 Months: 16.16%

6 Months: -44.87%

1 Year: -72.92%

YTD: -11.70%

About Acurx Pharmaceuticals, Inc. (ACXP)

Dive into the latest financial snapshot of Acurx Pharmaceuticals, Inc. (ACXP). With a current trading price of 2.04, the stock has experienced a daily shift of +$0.11 / 5.39%. The company's market capitalization stands impressively at 8,466,544. Track its year-to-date performance, which is at -11.70%, alongside its weekly, monthly, and yearly trends.

Company Details

Employees: 4

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Selected stocks

Quoin Pharmaceuticals, Ltd. (QNRX)

USA Oil ETF (USO)

SmartRent, Inc. (SMRT)

Arq, Inc. (ARQ)

Intercure Ltd. (INCR)